Dextrose injection
Ended Awarded Last action
- Contract number
- SPE2DP26F0648
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $20,023
Award facts
- Contract value 100% obligated
- $20,023.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a $20,023 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for dextrose injection products. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply solutions to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group's PPV-G GEN V prime contract, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as a critical regional pharmaceutical supplier capable of fulfilling diverse and specialized medical supply requirements for military healthcare operations globally. The underlying IDC structure, which includes a 30-month base period and three 30-month option periods, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring medical needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DP26F0648?
SPE2DP26F0648 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 12, 2025.
How much is contract SPE2DP26F0648 worth?
The government has obligated $20,023 on SPE2DP26F0648.
Is contract SPE2DP26F0648 an order under another contract?
Yes. SPE2DP26F0648 is a delivery order under SPE2DX25D9900, an indefinite delivery contract.
Was contract SPE2DP26F0648 competed?
The extent of competition for SPE2DP26F0648 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award